Activity of 2 genes will inform anti-cancer drug prescription

Image 1. GD2 molecule identification. Credit: Daria Sokol/MIPT Press Office

Bioinformaticians from the Moscow Institute of Physics and Technology and their colleagues have developed a technique for identifying ganglioside GD2 molecules, which are actively synthesized by cancer cells and thus serve as a therapeutic target. Reported in Biomedicines, the research findings will make cancer therapies using GD2-specific antibodies more effective.